Ligand validation:3VBI

0FX: dTDP-4-amino-4,6-dideoxyglucose

0FX is a Ligand Of Interest in 3VBI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VBI_0FX_E_1500	93%	24%	0.074	0.967	1.09	2.14	2	14	3	0	100%	1
3VBI_0FX_C_1500	89%	24%	0.078	0.957	1.11	2.15	3	18	3	0	100%	1
3VBI_0FX_A_1500	71%	24%	0.1	0.921	1.13	2.14	3	16	2	0	100%	1
3VBL_0FX_E_1500	89%	24%	0.091	0.97	1.11	2.14	3	16	0	0	100%	1
3VBK_0FX_E_1500	84%	24%	0.105	0.969	1.15	2.13	4	14	0	0	100%	1
5VYQ_0FX_A_302	97%	14%	0.065	0.98	1.78	2.26	5	17	0	0	100%	1
4YFY_0FX_B_301	80%	12%	0.098	0.946	2.15	2.07	12	12	0	0	100%	1
4NV1_0FX_E_301	79%	9%	0.103	0.948	2.11	2.55	4	22	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.